glp 1 select trial Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design A diabetes drug. Then a

Originally approved to help people with Type 2 diabetes, the class of medications known as GLP-1 agonists and dual GIP/GLP-1s quickly acquired a reputation for helping people shed stubborn pounds

However, semaglutide is prescribed for diabetes under the brand name Ozempic

doi: 10.3390/biology10010018 161 JhaJCBanalCChowBSMCooperMEJandeleit-DahmK

18, 2026) Wellstar Health System announced today that Thomas A

& Cohen, P

For most licensed weight loss medicines, menstrual changes are not a direct pharmacological effect of the drug itself, but rather a secondary consequence of significant or rapid weight loss and the associated changes in energy availability and body composition